nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—SIRT5—Signaling events mediated by HDAC Class I—YY1—cervical cancer	0.0468	0.106	CbGpPWpGaD
Suramin—F2—Common Pathway—SERPIND1—cervical cancer	0.0229	0.052	CbGpPWpGaD
Suramin—P2RY2—epithelium—cervical cancer	0.0226	0.0404	CbGeAlD
Suramin—P2RY2—renal system—cervical cancer	0.0209	0.0375	CbGeAlD
Suramin—F2—Intrinsic Pathway—SERPIND1—cervical cancer	0.0195	0.0443	CbGpPWpGaD
Suramin—F2—Intrinsic Pathway—GP5—cervical cancer	0.0171	0.0387	CbGpPWpGaD
Suramin—P2RY2—female reproductive system—cervical cancer	0.0168	0.03	CbGeAlD
Suramin—FSHR—female reproductive system—cervical cancer	0.0158	0.0282	CbGeAlD
Suramin—FSHR—female gonad—cervical cancer	0.0143	0.0257	CbGeAlD
Suramin—SIRT1—SREBP signalling—YY1—cervical cancer	0.014	0.0317	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class I—YY1—cervical cancer	0.0139	0.0314	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.0136	0.0309	CbGpPWpGaD
Suramin—SIRT1—E2F transcription factor network—YY1—cervical cancer	0.0134	0.0303	CbGpPWpGaD
Suramin—F2—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.0132	0.0298	CbGpPWpGaD
Suramin—SIRT5—decidua—cervical cancer	0.0132	0.0236	CbGeAlD
Suramin—P2RX4—uterine cervix—cervical cancer	0.0131	0.0234	CbGeAlD
Suramin—SIRT5—renal system—cervical cancer	0.0129	0.0231	CbGeAlD
Suramin—SIRT5—endometrium—cervical cancer	0.0125	0.0224	CbGeAlD
Suramin—P2RX4—decidua—cervical cancer	0.0124	0.0223	CbGeAlD
Suramin—P2RX4—renal system—cervical cancer	0.0122	0.0219	CbGeAlD
Suramin—P2RX4—endometrium—cervical cancer	0.0118	0.0212	CbGeAlD
Suramin—SIRT1—epithelium—cervical cancer	0.0115	0.0207	CbGeAlD
Suramin—F2—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.0115	0.0261	CbGpPWpGaD
Suramin—SIRT1—uterine cervix—cervical cancer	0.0114	0.0205	CbGeAlD
Suramin—P2RX4—mammalian vulva—cervical cancer	0.0114	0.0205	CbGeAlD
Suramin—F2—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.0113	0.0255	CbGpPWpGaD
Suramin—FSHR—G alpha (s) signalling events—TAAR6—cervical cancer	0.011	0.0248	CbGpPWpGaD
Suramin—SIRT1—decidua—cervical cancer	0.0109	0.0195	CbGeAlD
Suramin—ARSA—decidua—cervical cancer	0.0108	0.0193	CbGeAlD
Suramin—SIRT1—renal system—cervical cancer	0.0107	0.0192	CbGeAlD
Suramin—ARSA—renal system—cervical cancer	0.0106	0.0189	CbGeAlD
Suramin—SIRT1—endometrium—cervical cancer	0.0104	0.0185	CbGeAlD
Suramin—SIRT5—female reproductive system—cervical cancer	0.0103	0.0185	CbGeAlD
Suramin—SIRT1—mammalian vulva—cervical cancer	0.01	0.0179	CbGeAlD
Suramin—P2RX4—female reproductive system—cervical cancer	0.00979	0.0175	CbGeAlD
Suramin—SIRT1—uterus—cervical cancer	0.00954	0.0171	CbGeAlD
Suramin—SIRT5—female gonad—cervical cancer	0.00942	0.0169	CbGeAlD
Suramin—SIRT5—vagina—cervical cancer	0.00936	0.0168	CbGeAlD
Suramin—RYR1—mammalian vulva—cervical cancer	0.00925	0.0166	CbGeAlD
Suramin—P2RX4—female gonad—cervical cancer	0.00891	0.0159	CbGeAlD
Suramin—F2—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.00887	0.0201	CbGpPWpGaD
Suramin—P2RX4—vagina—cervical cancer	0.00885	0.0158	CbGeAlD
Suramin—RYR1—uterus—cervical cancer	0.00881	0.0158	CbGeAlD
Suramin—SIRT1—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.00879	0.0199	CbGpPWpGaD
Suramin—SIRT1—SREBF and miR33 in cholesterol and lipid homeostasis—MTOR—cervical cancer	0.00869	0.0197	CbGpPWpGaD
Suramin—SIRT1—female reproductive system—cervical cancer	0.00858	0.0154	CbGeAlD
Suramin—ARSA—female reproductive system—cervical cancer	0.00847	0.0152	CbGeAlD
Suramin—PLA2G2A—epithelium—cervical cancer	0.00808	0.0145	CbGeAlD
Suramin—RYR1—female reproductive system—cervical cancer	0.00792	0.0142	CbGeAlD
Suramin—SIRT1—female gonad—cervical cancer	0.0078	0.014	CbGeAlD
Suramin—SIRT1—vagina—cervical cancer	0.00776	0.0139	CbGeAlD
Suramin—ARSA—female gonad—cervical cancer	0.00771	0.0138	CbGeAlD
Suramin—ARSA—vagina—cervical cancer	0.00766	0.0137	CbGeAlD
Suramin—PLA2G2A—decidua—cervical cancer	0.00764	0.0137	CbGeAlD
Suramin—PLA2G2A—renal system—cervical cancer	0.0075	0.0134	CbGeAlD
Suramin—PLA2G2A—endometrium—cervical cancer	0.00725	0.013	CbGeAlD
Suramin—RYR1—vagina—cervical cancer	0.00717	0.0128	CbGeAlD
Suramin—FSHR—FSH signaling pathway—MTOR—cervical cancer	0.00715	0.0162	CbGpPWpGaD
Suramin—PLA2G2A—mammalian vulva—cervical cancer	0.00701	0.0126	CbGeAlD
Suramin—SIRT5—Signaling events mediated by HDAC Class I—STAT3—cervical cancer	0.00697	0.0158	CbGpPWpGaD
Suramin—F2—epithelium—cervical cancer	0.0061	0.0109	CbGeAlD
Suramin—SIRT5—lymph node—cervical cancer	0.00605	0.0108	CbGeAlD
Suramin—PLA2G2A—female reproductive system—cervical cancer	0.006	0.0108	CbGeAlD
Suramin—F2—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.00587	0.0133	CbGpPWpGaD
Suramin—P2RX4—lymph node—cervical cancer	0.00573	0.0103	CbGeAlD
Suramin—F2—renal system—cervical cancer	0.00566	0.0101	CbGeAlD
Suramin—PLA2G4A—uterine cervix—cervical cancer	0.00557	0.00998	CbGeAlD
Suramin—PLA2G2A—female gonad—cervical cancer	0.00546	0.00978	CbGeAlD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00541	0.0123	CbGpPWpGaD
Suramin—PLA2G4A—decidua—cervical cancer	0.00531	0.00951	CbGeAlD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00523	0.0118	CbGpPWpGaD
Suramin—PLA2G4A—renal system—cervical cancer	0.00521	0.00933	CbGeAlD
Suramin—F2—PAR1-mediated thrombin signaling events—AKAP13—cervical cancer	0.00519	0.0118	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—WNT5A—cervical cancer	0.00509	0.0115	CbGpPWpGaD
Suramin—PLA2G4A—endometrium—cervical cancer	0.00504	0.00902	CbGeAlD
Suramin—SIRT1—lymph node—cervical cancer	0.00502	0.00898	CbGeAlD
Suramin—ARSA—lymph node—cervical cancer	0.00496	0.00887	CbGeAlD
Suramin—PLA2G4A—mammalian vulva—cervical cancer	0.00488	0.00873	CbGeAlD
Suramin—SIRT1—Circadian rythm related genes—UBE3A—cervical cancer	0.00458	0.0104	CbGpPWpGaD
Suramin—F2—female reproductive system—cervical cancer	0.00453	0.00812	CbGeAlD
Suramin—SIRT1—Cellular response to heat stress—MTOR—cervical cancer	0.00435	0.00985	CbGpPWpGaD
Suramin—PLA2G4A—female reproductive system—cervical cancer	0.00418	0.00748	CbGeAlD
Suramin—F2—female gonad—cervical cancer	0.00413	0.00739	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—TAAR6—cervical cancer	0.00412	0.00934	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—TAAR6—cervical cancer	0.00398	0.00902	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00389	0.00881	CbGpPWpGaD
Suramin—PLA2G4A—female gonad—cervical cancer	0.0038	0.0068	CbGeAlD
Suramin—PLA2G4A—vagina—cervical cancer	0.00378	0.00676	CbGeAlD
Suramin—SIRT1—Cellular responses to stress—CA9—cervical cancer	0.00353	0.008	CbGpPWpGaD
Suramin—PLA2G2A—lymph node—cervical cancer	0.00351	0.00629	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—WNT2—cervical cancer	0.00322	0.00729	CbGpPWpGaD
Suramin—SIRT1—FoxO family signaling—CTNNB1—cervical cancer	0.00315	0.00713	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—WNT2—cervical cancer	0.00311	0.00704	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00309	0.00699	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00282	0.00639	CbGpPWpGaD
Suramin—SIRT1—SREBP signalling—MTOR—cervical cancer	0.0027	0.00611	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.0027	0.00611	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class III—TP53—cervical cancer	0.00251	0.00569	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00247	0.00559	CbGpPWpGaD
Suramin—PLA2G4A—lymph node—cervical cancer	0.00244	0.00437	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—WNT5A—cervical cancer	0.00244	0.00552	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—WNT5A—cervical cancer	0.00236	0.00534	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—TAAR6—cervical cancer	0.00233	0.00528	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—MTOR—cervical cancer	0.00232	0.00527	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—TAAR6—cervical cancer	0.00225	0.0051	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TAAR6—cervical cancer	0.00212	0.00479	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class I—STAT3—cervical cancer	0.00206	0.00467	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TAAR6—cervical cancer	0.00204	0.00463	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.00198	0.00448	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.00195	0.00442	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00175	0.00397	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—STAT3—cervical cancer	0.0017	0.00385	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—MTOR—cervical cancer	0.00166	0.00375	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—WNT2—cervical cancer	0.00165	0.00374	CbGpPWpGaD
Suramin—F2—Folate Metabolism—MTHFR—cervical cancer	0.00161	0.00364	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AKAP13—cervical cancer	0.0016	0.00362	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—WNT2—cervical cancer	0.0016	0.00361	CbGpPWpGaD
Suramin—F2—Hemostasis—GP6—cervical cancer	0.00159	0.0036	CbGpPWpGaD
Suramin—F2—Hemostasis—SERPIND1—cervical cancer	0.00159	0.0036	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00155	0.0035	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—EGFR—cervical cancer	0.00155	0.0035	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AKAP13—cervical cancer	0.00154	0.00349	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—cervical cancer	0.00147	0.00333	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SERPIND1—cervical cancer	0.00145	0.00329	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—GP6—cervical cancer	0.00145	0.00329	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.00145	0.00329	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AKAP13—cervical cancer	0.00145	0.00328	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.00144	0.00327	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AKAP13—cervical cancer	0.0014	0.00317	CbGpPWpGaD
Suramin—F2—Hemostasis—GP5—cervical cancer	0.00139	0.00315	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.00133	0.003	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00132	0.00298	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—STAT3—cervical cancer	0.00128	0.0029	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.00128	0.0029	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00128	0.00289	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—GP5—cervical cancer	0.00127	0.00288	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—WNT5A—cervical cancer	0.00125	0.00284	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TAAR6—cervical cancer	0.00125	0.00283	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—WNT5A—cervical cancer	0.00121	0.00274	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TAAR6—cervical cancer	0.00121	0.00273	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—TAAR6—cervical cancer	0.00118	0.00267	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—CASP3—cervical cancer	0.00116	0.00263	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—CASP8—cervical cancer	0.00115	0.00261	CbGpPWpGaD
Suramin—PLA2G4A—PDGF Pathway—STAT3—cervical cancer	0.00111	0.00252	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.0011	0.00249	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00106	0.0024	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.00101	0.00229	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000989	0.00224	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—WNT2—cervical cancer	0.000976	0.00221	CbGpPWpGaD
Suramin—ARSA—Metabolism—CA9—cervical cancer	0.000949	0.00215	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—WNT2—cervical cancer	0.000942	0.00213	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—RARB—cervical cancer	0.00093	0.00211	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000927	0.0021	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—MTOR—cervical cancer	0.000922	0.00209	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—WNT2—cervical cancer	0.00092	0.00208	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—EGFR—cervical cancer	0.000887	0.00201	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—CASP3—cervical cancer	0.000871	0.00197	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AKAP13—cervical cancer	0.000857	0.00194	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000851	0.00193	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000839	0.0019	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AKAP13—cervical cancer	0.000827	0.00187	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000767	0.00174	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—cervical cancer	0.000744	0.00169	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—WNT5A—cervical cancer	0.000739	0.00167	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—STAT3—cervical cancer	0.000732	0.00166	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—WNT5A—cervical cancer	0.000714	0.00162	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—STAT3—cervical cancer	0.000713	0.00161	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000705	0.0016	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—WNT5A—cervical cancer	0.000697	0.00158	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—cervical cancer	0.000677	0.00153	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TAAR6—cervical cancer	0.000666	0.00151	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—EGFR—cervical cancer	0.000665	0.00151	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NOTCH2—cervical cancer	0.000616	0.0014	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CA9—cervical cancer	0.000611	0.00138	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—cervical cancer	0.00061	0.00138	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TAAR6—cervical cancer	0.000605	0.00137	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TAAR6—cervical cancer	0.000553	0.00125	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—cervical cancer	0.000544	0.00123	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NOTCH2—cervical cancer	0.000519	0.00118	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NOTCH2—cervical cancer	0.000501	0.00114	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000492	0.00111	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—WNT2—cervical cancer	0.000472	0.00107	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AKAP13—cervical cancer	0.000456	0.00103	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—cervical cancer	0.000439	0.000994	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—WNT2—cervical cancer	0.000432	0.000978	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—CTNNB1—cervical cancer	0.000426	0.000965	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HES1—cervical cancer	0.000425	0.000964	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AKAP13—cervical cancer	0.000414	0.000939	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HES1—cervical cancer	0.000411	0.000931	CbGpPWpGaD
Suramin—ARSA—Metabolism—MTHFR—cervical cancer	0.000385	0.000872	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NOTCH1—cervical cancer	0.000381	0.000864	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AKAP13—cervical cancer	0.000379	0.000858	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000379	0.000858	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TERT—cervical cancer	0.000373	0.000844	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000372	0.000843	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TERT—cervical cancer	0.00036	0.000816	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000359	0.000812	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—WNT5A—cervical cancer	0.000358	0.00081	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TAAR6—cervical cancer	0.000357	0.000809	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FGFR3—cervical cancer	0.000342	0.000775	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FGFR3—cervical cancer	0.00033	0.000748	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—WNT5A—cervical cancer	0.000327	0.000741	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TAAR6—cervical cancer	0.000327	0.00074	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NOTCH1—cervical cancer	0.000321	0.000728	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NOTCH1—cervical cancer	0.00031	0.000703	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CA9—cervical cancer	0.000288	0.000652	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EGFR—cervical cancer	0.000286	0.000648	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000284	0.000644	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000283	0.00064	CbGpPWpGaD
Suramin—F2—Signaling Pathways—WNT2—cervical cancer	0.000279	0.000631	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EGFR—cervical cancer	0.000276	0.000626	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—WNT2—cervical cancer	0.000255	0.000578	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MTHFR—cervical cancer	0.000248	0.000562	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKAP13—cervical cancer	0.000245	0.000554	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MTOR—cervical cancer	0.000241	0.000545	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000239	0.00054	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MTOR—cervical cancer	0.000232	0.000527	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKAP13—cervical cancer	0.000224	0.000507	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CASP3—cervical cancer	0.000221	0.000501	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CASP3—cervical cancer	0.000214	0.000484	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CTNNB1—cervical cancer	0.000213	0.000483	CbGpPWpGaD
Suramin—F2—Signaling Pathways—WNT5A—cervical cancer	0.000211	0.000479	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CTNNB1—cervical cancer	0.000206	0.000467	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—WNT5A—cervical cancer	0.000193	0.000438	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STAT3—cervical cancer	0.000186	0.000421	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STAT3—cervical cancer	0.00018	0.000407	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—cervical cancer	0.000169	0.000383	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—cervical cancer	0.000163	0.00037	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOTCH2—cervical cancer	0.000148	0.000336	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—cervical cancer	0.000142	0.000322	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CTNNB1—cervical cancer	0.000141	0.00032	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—cervical cancer	0.000137	0.000311	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOTCH2—cervical cancer	0.000136	0.000307	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HES1—cervical cancer	0.000122	0.000275	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—cervical cancer	0.00012	0.000271	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MTHFR—cervical cancer	0.000117	0.000265	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HES1—cervical cancer	0.000111	0.000252	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—cervical cancer	0.000109	0.000248	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TERT—cervical cancer	0.000107	0.000241	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGFR3—cervical cancer	9.78e-05	0.000221	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TERT—cervical cancer	9.74e-05	0.000221	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOTCH1—cervical cancer	9.18e-05	0.000208	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGFR3—cervical cancer	8.94e-05	0.000203	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOTCH1—cervical cancer	8.4e-05	0.00019	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—cervical cancer	8.18e-05	0.000185	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—cervical cancer	7.48e-05	0.000169	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MTOR—cervical cancer	6.88e-05	0.000156	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP3—cervical cancer	6.33e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MTOR—cervical cancer	6.29e-05	0.000142	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CTNNB1—cervical cancer	6.1e-05	0.000138	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP3—cervical cancer	5.79e-05	0.000131	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CTNNB1—cervical cancer	5.58e-05	0.000126	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STAT3—cervical cancer	5.32e-05	0.00012	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STAT3—cervical cancer	4.86e-05	0.00011	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—cervical cancer	4.83e-05	0.000109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—cervical cancer	4.42e-05	0.0001	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—cervical cancer	4.06e-05	9.19e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—cervical cancer	3.71e-05	8.4e-05	CbGpPWpGaD
